Nuvalent Inc vs Vanguard S&P 500 Growth Index Fund ETF — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Vanguard S&P 500 Growth Index Fund ETF trades at $82.03. The key difference: Nuvalent Inc is trading nearer its 52-week high, Vanguard S&P 500 Growth Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| NUVL | VOOG | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $123.96 | $85.11 |
52-Week Low | $72.16 | $65.32 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →VOOG is an index-based ETF that tracks the S&P 500 Growth Index, composed of the growth-oriented companies within the S&P 500. It selects constituents based on three key metrics—sales growth, the ratio of earnings change to price, and momentum—offering a highly liquid and low-cost way to capture the high-performing 'growth slice' of the broader U.S. large-cap market.
Read more on VOOG →